<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Biomimetics Therapeutics Expands into New Markets with Innovative GEM OS Combination Device</title>
	<atom:link href="http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/feed/" rel="self" type="application/rss+xml" />
	<link>http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/</link>
	<description>Stem cells, biomaterials, engineered tissues, and other cell-based technologies.  The guts of the Regenerative Medine industry.</description>
	<lastBuildDate>Tue, 28 Feb 2012 16:01:55 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: carlyle01</title>
		<link>http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-22</link>
		<dc:creator><![CDATA[carlyle01]]></dc:creator>
		<pubDate>Mon, 14 Jan 2008 22:01:19 +0000</pubDate>
		<guid isPermaLink="false">http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-22</guid>
		<description><![CDATA[Thanks, understood.  I&#039;ll check out Athersys&#039; website.]]></description>
		<content:encoded><![CDATA[<p>Thanks, understood.  I&#8217;ll check out Athersys&#8217; website.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: jrowley</title>
		<link>http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-20</link>
		<dc:creator><![CDATA[jrowley]]></dc:creator>
		<pubDate>Sat, 12 Jan 2008 23:39:56 +0000</pubDate>
		<guid isPermaLink="false">http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-20</guid>
		<description><![CDATA[I really can&#039;t comment too much specifically on Aastrom, not because I don&#039;t know, but management wants me to keep Aastrom comments to a minimum so as not to look like I am pumping the stock.  However, what you suggest is the strategy for most cell therapy companies.  The best description of this strategy is spelled out on the Athersys website where they describe their cellular product and what it does.....

Thanks for the comment.]]></description>
		<content:encoded><![CDATA[<p>I really can&#8217;t comment too much specifically on Aastrom, not because I don&#8217;t know, but management wants me to keep Aastrom comments to a minimum so as not to look like I am pumping the stock.  However, what you suggest is the strategy for most cell therapy companies.  The best description of this strategy is spelled out on the Athersys website where they describe their cellular product and what it does&#8230;..</p>
<p>Thanks for the comment.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: carlyle01</title>
		<link>http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-17</link>
		<dc:creator><![CDATA[carlyle01]]></dc:creator>
		<pubDate>Wed, 09 Jan 2008 19:37:44 +0000</pubDate>
		<guid isPermaLink="false">http://regeneration-station.com/2008/01/08/biomimetics-therapeutics-announces-positive-results-for-its-recombinant-protein-product-gem-os1-for-foot-and-anke-fusions/#comment-17</guid>
		<description><![CDATA[I take it this is the growth path that Aastrom hopes to follow - approval of a first product and then continued approval of subsequent products using the same platform.]]></description>
		<content:encoded><![CDATA[<p>I take it this is the growth path that Aastrom hopes to follow &#8211; approval of a first product and then continued approval of subsequent products using the same platform.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

